Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58.6M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
60.9M
-
Shares change
-
-5.04M
-
Total reported value, excl. options
-
$2.81B
-
Value change
-
-$244M
-
Put/Call ratio
-
1.25
-
Number of buys
-
56
-
Number of sells
-
-103
-
Price
-
$46.15
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q3 2021
213 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q3 2021.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.9M shares
.
Largest 10 shareholders include FMR LLC (6.85M shares), BlackRock Inc. (5.76M shares), VANGUARD GROUP INC (5.45M shares), WELLINGTON MANAGEMENT GROUP LLP (5.18M shares), Bellevue Group AG (4.34M shares), JPMORGAN CHASE & CO (4.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.03M shares), Rock Springs Capital Management LP (2.56M shares), STATE STREET CORP (2.39M shares), and Casdin Capital, LLC (2.17M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.